Track papers across labs, topics, and trends.
Search papers, labs, and topics across Lattice.
HistoAtlas is introduced as a pan-cancer computational atlas, extracting 38 histomic features from over 6,700 H&E slides across 21 cancer types in TCGA. The study systematically links these features to survival rates, gene expression, somatic mutations, and immune subtypes, adjusting for covariates and correcting for multiple testing. The atlas identifies both known biological associations and novel compartment-specific immune signals and morphological subtypes, all traceable to tissue compartments and individual cells.
Unlock a treasure trove of cancer insights: HistoAtlas links 38 interpretable histomic features to survival, gene expression, and more across 21 cancer types, all from routine H&E slides.
We present HistoAtlas, a pan-cancer computational atlas that extracts 38 interpretable histomic features from 6,745 diagnostic H&E slides across 21 TCGA cancer types and systematically links every feature to survival, gene expression, somatic mutations, and immune subtypes. All associations are covariate-adjusted, multiple-testing corrected, and classified into evidence-strength tiers. The atlas recovers known biology, from immune infiltration and prognosis to proliferation and kinase signaling, while uncovering compartment-specific immune signals and morphological subtypes with divergent outcomes. Every result is spatially traceable to tissue compartments and individual cells, statistically calibrated, and openly queryable. HistoAtlas enables systematic, large-scale biomarker discovery from routine H&E without specialized staining or sequencing. Data and an interactive web atlas are freely available at https://histoatlas.com .